Authors
Chen-Xuan Kang, Jing-Ya Ding, Yu-Fang Lo, Tsai-Yi Wu, Han-Po Shih, Jhan-Jie Peng, Kung-Wei Lin, You-Ning Lin, Chia-Chi Lo, Shao-Hsuan Hsia, Jainn-Jim Lin, En-Pei Lee, Oi-Wa Chan, Yhu-Chering Huang, Chih-Jung Chen, Tzou-Yien Lin, Cheng-Lung Ku, Chen-Yen Kuo
Published in
Journal of human immunity. Volume 2. Issue 6. Nov 02, 2026. Epub Oct 13, 2026.
Abstract
Neutralizing autoantibodies (auto-Abs) against type I IFNs (IFN-α and IFN-ω) have emerged as major acquired risk factors for severe viral infections. Human adenovirus (HAdV) is highly prevalent in children and can cause severe pneumonia, but the host determinants of disease severity remain poorly understood. We describe here a 5-year-old child with life-threatening HAdV-B7 pneumonia requiring intensive care who carried high-titer anti-IFN-ω auto-Abs of the IgG1 and IgG3 subclasses. Peripheral blood mononuclear cells produced normal amounts of IFN-α and IFN-ω ex vivo; however, IFN-ω was undetectable in the plasma during acute illness. Functional assays demonstrated that the patient's plasma strongly neutralized IFN-ω, abolishing its antiviral signaling and protective effects, resulting in high levels of adenovirus replication and virus-induced cytotoxicity. These findings implicate anti-IFN-ω auto-Abs in severe adenoviral infection and support immunological screening of pediatric patients with unexplained severe viral pneumonia, which may guide targeted management.
PMID:
42867380
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0